Lv2
130 积分 2022-03-18 加入
Linker Design for The Antibody Drug Conjugates: A Comprehensive Review
1小时前
已完结
A comparison of the activity, lysosomal stability, and efficacy of legumain-cleavable and cathepsin cleavable ADC linkers
2小时前
已完结
A comparison of the activity, lysosomal stability, and efficacy of legumain-cleavable and cathepsin cleavable ADC linkers
2小时前
已完结
One-Step Conjugation Method for Site-Specific Antibody–Drug Conjugates through Reactive Cysteine-Engineered Antibodies
1天前
已完结
High-Throughput Experimentation Reveals Scope and Limitations of Selective Phosphine Reductants and Enables One-Pot mAb Reduction/Conjugation
1天前
已完结
A Platform for the Generation of Site-Specific Antibody–Drug Conjugates That Allows for Selective Reduction of Engineered Cysteines
1天前
已完结
DX‐8951f: Summary of Phase I Clinical Trials
28天前
已完结
Phase I and pharmacokinetic study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f ), using a weekly 30-minute intravenous infusion, in patients with advanced solid malignancies
28天前
已完结
Phase I and Pharmacokinetic Study of the Camptothecin Analog DX-8951f Administered as a 30-Minute Infusion Every 3 Weeks in Patients With Advanced Cancer
28天前
已关闭
In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells
1个月前
已关闭
皖公网安备34019202002308
